Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression
- 15 December 1993
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 34 (12) , 839-852
- https://doi.org/10.1016/0006-3223(93)90052-f
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- In Vitro and In Vivo Inhibition of Inositol Monophosphatase by the Bisphosphonate L‐690,330Journal of Neurochemistry, 1993
- INOSITOL PASSES THE BLOOD BRAIN BEHAVIOR SUFFICIENTLY TO REVERSE LITHIUM EFFECTS ON BEHAVIOR IN RATSClinical Neuropharmacology, 1992
- Magnesium reversal of lithium inhibition of β-adrenergic and muscarinic receptor coupling to G proteinsBiochemical Pharmacology, 1991
- Lithium research: State of the artBiological Psychiatry, 1990
- ROLE OF INOSITOL‐1‐PHOSPHATASE INHIBITION IN THE MECHANISM OF ACTION OF LITHIUMBasic & Clinical Pharmacology & Toxicology, 1990
- Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithiumAmerican Journal of Psychiatry, 1989
- High-dose dietarymyo-inositol supplementation does not alter the ischaemia phenomenon in human diabeticsActa Neurologica Scandinavica, 1989
- Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortexNature, 1988
- Myo‐Inositol Turnover in the Intact Rat Brain: Increased Production after d‐AmphetamineJournal of Neurochemistry, 1981
- Reduced Brain Inositol in Lithium-treated RatsNature New Biology, 1971